Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
New ophthalmic dual-viscoelastic device in cataract surgery: a comparative study
Gaspare Monaco1, Mariangela Gari1, Silvia Pelizzari1,2
1Ophthalmology, Fatebenefratelli e Oftalmico Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
This study compared two ophthalmic viscoelastic devices (OVDs) in cataract surgery. While both were effective, Viscopack14 caused more endothelial cell loss, and DuoVisc led to higher intraocular pressure (IOP) spikes.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Biomaterials Science
Background:
- Ophthalmic viscoelastic devices (OVDs) are crucial for maintaining anterior chamber space during cataract surgery.
- Different OVDs possess varying cohesive and dispersive properties, impacting surgical outcomes and safety.
- Understanding the comparative performance of OVDs with distinct characteristics is essential for optimizing surgical techniques.
Purpose of the Study:
- To compare the clinical performance and safety of two distinct ophthalmic viscoelastic devices (OVDs) during cataract surgery.
- To evaluate the impact of Viscopack14 and DuoVisc on key postoperative parameters including endothelial cell count, intraocular pressure (IOP), and visual acuity.
- To determine if differences in OVD properties translate to significant clinical outcomes in patients undergoing phacoemulsification and intraocular lens implantation.
Main Methods:
- A prospective, randomized, controlled clinical study involving 127 patients undergoing cataract surgery.
- Each patient received either OVD1 (Viscopack14) or OVD2 (DuoVisc) during phacoemulsification and intraocular lens implantation.
- Postoperative outcomes including endothelial cell count, IOP, central corneal thickness (CCT), intraocular inflammation, and corrected distance visual acuity (CDVA) were assessed at 3 months.
Main Results:
- Postoperative mean endothelial cell loss was 14.4% for OVD1 and 7.1% for OVD2 (p=0.08).
- The incidence of IOP spikes at 2 hours was 0% for OVD1 and 8% for OVD2 (p=0.02).
- OVD2 group showed significantly higher postoperative IOP values from 24 hours onwards (p<0.05), with no significant differences in CCT, inflammation, or CDVA.
Conclusions:
- Both OVDs demonstrated comparable clinical performance and effectiveness in cataract surgery.
- Viscopack14 was associated with greater corneal endothelial cell reduction compared to DuoVisc.
- DuoVisc exhibited a higher incidence of intraocular pressure (IOP) values and spikes, necessitating further investigation.
More Related Videos
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
07:53Establishment of a Clinically Relevant Ex Vivo Mock Cataract Surgery Model for Investigating Epithelial Wound Repair in a Native Microenvironment
Published on: June 5, 2015
Related Concept Videos
05:19Modeling Cataract Surgery in Mice
04:59Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
07:53Establishment of a Clinically Relevant Ex Vivo Mock Cataract Surgery Model for Investigating Epithelial Wound Repair in a Native Microenvironment
11:46Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model
08:47Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
06:39Biological Preparation and Mechanical Technique for Determining Viscoelastic Properties of Zonular Fibers